Fairvalue-Calculator Fairvalue-Calculator
EN DE

J2KBIO Co (420570) Fair Value & Analysis

Basic Materials · KR · Market cap 43.0B KRW

Price7,040 KRW
Fair Value9,142 KRW
Upside+29.9%
Quality95/100
Evidence: High Range 6,856 KRW – 11,427 KRW

Fair value as of: Jun 24, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

J2KBIO Co (420570) currently trades at 7,040 KRW, while our model-based Fair Value estimate is 9,142 KRW — implying the stock looks roughly 29.9% undervalued today. We read business quality at 95/100 (high quality), in the Basic Materials sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high) — always confirm before acting.

About the company

J2KBIO Co., Ltd., a bio venture company, offers active ingredients for cosmetics, functional food, and household products from natural materials and microbial fermentation. The company was founded in 2014 and is based in Cheongju, South Korea.

Open the full interactive analysis →

Similar stocks

Linde plc (LIN) -69% L'Air Liquide S.A (AIQUY) -59% Air Products and Chemicals, Inc (A1PD34) -86% Intercontinental Exchange, Inc (I1CE34) -80% Wanhua Chemical Group (600309) -8% Asian Paints Limited (ASIANPAINT) -75%

Frequently asked questions

Is J2KBIO Co (420570) undervalued?
As of Jun 24, 2026, our model estimates a fair value of 9,142 KRW versus a price of 7,040 KRW — about +30% (undervalued). Model-based estimate, not financial advice.
What is the fair value of 420570?
Our 21-model fair value for J2KBIO Co is 9,142 KRW (as of Jun 24, 2026), built from audited fundamentals. The current price is 7,040 KRW.
What is the quality score of 420570?
J2KBIO Co has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.